RBM8A and neoplasm: Increased RBM8A expression (HR=0.421, 95%CI=0.301−0.662; P<0.001) was significantly associated with a poor survival in univariate analysis, along with other prognostic markers, involving age (HR= 2.228, 95%CI=0.522−0.892; P=0.048), tumor size (HR=0.415, 95%CI=0.283−0.781; P< 0.003), TNM stage (HR=7.883, 95%CI=5.839−9.302; P<0.001), lymph node metastasis (HR=1.992, 95%CI=1.672-2.198; P<0.001), and distant metastasis (HR=6.892, 95%CI=2.199−14.212; P<0.001).